Effectiveness and safety of ustekinumab dose escalation in Crohn's disease: a multicenter observational study.

Raúl Vicente Olmedo MartínJuan María Vázquez MorónMaría Del Mar Martín RodríguezMarta Lázaro SáezÁlvaro Hernández MartínezFederico Argüelles-Arias

Published in: Revista espanola de enfermedades digestivas (2023)

Ustekinumab dose escalation was effective in recapturing response in over half of the patients. These findings suggest that dose escalation should be considered in patients who experience loss or partial response to the standard maintenance.

Keyphrases

open label
end stage renal disease
newly diagnosed
ejection fraction
randomized controlled trial
clinical trial
patient reported